SCHEMBL13057791

SCHEMBL13057791

C=C1N(C)CCCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26791451 0.93 INMT (0.39)
SCHEMBL9945748 0.86
SCHEMBL25758669 0.77 INMT (0.31)
SCHEMBL27420473 0.77 INMT (0.30)
SCHEMBL14818718 0.74
SCHEMBL13057847 0.70
SCHEMBL266971 0.69
SCHEMBL24899342 0.67
SCHEMBL266970 0.67
SCHEMBL82580 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3680272-B1 CATALYST SYSTEM FOR THE PREPARATION OF HIGH-MOLECULAR WEIGHT POLYETHER AND APPLICATION THEREOF UNIV STUTTGART (DE) 2023-08-23 EP disclosed
WO-2020144293-A1 CATALYST SYSTEM FOR THE PREPARATION OF HIGH-MOLECULAR WEIGHT POLYETHER AND APPLICATION THEREOF Universität Stuttgart (DE) 2020-07-16 WO disclosed
EP-3680272-A1 CATALYST SYSTEM FOR THE PREPARATION OF HIGH-MOLECULAR WEIGHT POLYETHER AND APPLICATION THEREOF Universität Stuttgart (DE) 2020-07-15 EP disclosed
EP-3124561-A1 ACTIVE ENERGY RAY-CURABLE INKJET INK Toyo Ink SC Holdings Co., Ltd. (JP) 2017-02-01 EP disclosed
US-8901141-B2 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2014-12-02 US disclosed
US-8785460-B2 Tricyclic compounds and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-07-22 US disclosed
US-20100298287-A1 TRICYCLIC COMPOUNDS HAVING CORTICOTROPIN-RELEASING FACTOR ANTAGONISTIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-11-25 US disclosed
US-7655804-B2 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases ONO PHARMACEUTICAL CO., LTD. (JP) 2010-02-02 US disclosed
US-20090186879-A1 TRICYCLIC COMPOUNDS AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-07-23 US disclosed